Clinical Study
Stand-Alone Lateral Interbody Fusion for the Treatment of Low-Grade Degenerative Spondylolisthesis
Table 1
Demographic and clinical data.
| Patients (n) | 52 | Age (years) | 67.6 ± 10.0 | Female | 38 (73.1%) | BMI (m/kg2) | 27.4 ± 3.3 | Pre-op VAS | 77.9 ± 21.8 | Pre-op ODI | 66.0 ± 16.8 | Olisthesis | 15.1% ± 5% | Spine levels | 52 | L1-2 | 2 (3.8%) | L2-3 | 9 (17.3%) | L3-4 | 14 (26.9%) | L4-5 | 27 (51.9%) | Blood loss (cc) | <50 | Surgery duration (min) | 73.2 ± 31.4 |
|
|